Gene Query: SRRM2

Dataset Description Geneva Score
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 190.84
CD95/Fas ligand mRNA is toxic to cells 119.63
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 111.87
Efficient and quantitative high-throughput tRNA sequencing 101.15
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 91.62
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 81.15
Transcriptomic analysis of human tonsillar TFH subsets 64.55
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 57.2
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 57.2
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 42.47
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 42.47
Argonaute proteins couple chromatin silencing to alternative splicing 41.62
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 41.62
Effect of BMP inhibition or stimulation of primary human keratinocytes 37.8
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 37.8
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 36.41
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 35.18
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 32.3
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 31.52
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 30.91
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 28.9
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 28.62
Tracking distinct RNA populations using efficient and reversible covalent chemistry 28.38
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 26.87
mRNA expression profile of Lymphocytes by high-throuput sequencing 26.56
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 26.4
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 26.4
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 25.92
Role of microRNAs in the interaction between Salmonella and the host cell 25.53
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 24.06
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 22.4
Comparison of microRNA Profiling Platforms 22.32
Comparison of microRNA Profiling Platforms (HTS) 22.32
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 22.12
circRNA-sequencing 21.34
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 20.23
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 19.45
Selective expression of long non-coding RNAs in a breast cancer cell progression model 18.84
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 18.48
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 18.37
Unique features and clinical importance of acute alloreactive immune responses 18.21
Cajal bodies are linked to genome conformation 18.19
Cajal bodies are linked to genome conformation [RNA-Seq] 18.19
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 17.79
The interplay between SOX4 and SMAD3 in the context of breast cancer 17.79
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 17.73
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 17.73
Regulation of highly expressed hCINAP on translatome 17.45
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 17.31
High-throughput sequencing of pluripotent cells 17.14
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 17.05
Global response to chemotherapy-induced apoptosis 16.74
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 16.4
Human neutrophil genome during PMA- and E. coli encounter-induced activation 16.4
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 16.33
Genome wide miR-191 target profile determined by RIP and gene expression profiling 16.33
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 16.18
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 16.13
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 16.07
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 16.07
Transcriptome analysis of CNS leukemia 16.0
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 16.0
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 15.81
Epigenetic reprogramming of melanoma cells by vitamin C treatment 15.75
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 15.53
Determination of tRNA aminoacylation levels by high throughput sequencing 15.39
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 15.39
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 15.36
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 14.87
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 14.76
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 14.59
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 14.37
Expression profiling of etoposide-induced senescent cells 14.35
Global analysis of enhancer targets: Mosaic-seq 14.05
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 13.88
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 13.86
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 13.81
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 13.79
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 13.64
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 13.63
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 13.57
Short and Long RNA sequencing of human mature erythrocytes 13.57
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 13.42
Next generation sequencing of small RNAs isolated from exosomes in human semen 13.37
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 13.02
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 13.02
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 12.82
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 12.82
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 12.81
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 12.77
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 12.77
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 12.66
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 12.66
Alteration of the microRNA network during the progression of Alzheimer’s disease 12.59
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 12.57
Systematic discovery of endogenous human ribonucleoprotein complexes 12.56
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 12.55
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 12.37
Landscape and variation of RNA secondary structure across the human transcriptome 12.35
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 12.27
Differential responses of human fetal brain neural stem cells to Zika virus infection 12.26
Exogenous rescue of KLHL9 in SF210 cell line 12.26
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 12.2
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 12.2
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 12.17
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 12.15
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 12.15
Role of XRN2 ribonucleolytic activity in RNA metabolism 12.07
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 12.04
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 11.88
circRNA-sequencing 11.83
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 11.78
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 11.78
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 11.76
An siRNA screen identifies CHD4 as a target for epigenetic therapy 11.65
Total RNA-seq in ALL-SIL upon TLX1 knockdown 11.56
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 11.55
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 11.55
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 11.37
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 11.36
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 11.32
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 11.3
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 11.3
DART-seq: an antibody-free method for global m6A detection 11.2
RNA seq comparison between scrambled and shGRP78 cells 11.2
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 11.18
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 11.15
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 11.15
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 11.05
NRDE2 negatively regulates nuclear exosome functions 11.02
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 10.96
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 10.93
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 10.85
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 10.72
Transcriptomes of oxLDL exposed trained monocytes 10.72
oxLDL exposed trained monocytes 10.72
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 10.35
Sensing self and nonself circular RNAs 10.35
The transcriptome and chromatin accessbility landscape of mammalian germline 10.34
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 10.3
Integrating single-cell transcriptomic data across different conditions, technologies, and species 10.28
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 9.92
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 9.92
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 9.88
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 9.87
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 9.87
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 9.24
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 9.17
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 9.14
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 9.08
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 9.08
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 9.08
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 9.08
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.96
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 8.9
An RNA-centric dissection of host complexes controlling flavivirus infection 8.87
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 8.87
Oncogenic MYC induces a dependency on the spliceosome in human cancer 8.83
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 8.73
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 8.73
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 8.71
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 8.64
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 8.6
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.56
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 8.55
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 8.49
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 8.49
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 8.38
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 8.34
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 8.27
Stem and effector CD8 T-cells from human cancers 8.27
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 8.24
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 8.24
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 8.21
Expression profiling of MCF-7 cells with treatment of TCDD 8.21
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 8.16
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 8.09
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 8.04
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  8.03
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 8.03
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 7.98
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 7.98
Cerebellar differentiation in Ataxia-Telangiectasia 7.96
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 7.93
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 7.93
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 7.9
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 7.85
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 7.85
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 7.82
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 7.71
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.68
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 7.6
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 7.6
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 7.56
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 7.55
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 7.53
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 7.51
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 7.49
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 7.45
RNA-seq analyses of human prostate cancer cells 7.44
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 7.4
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 7.36
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 7.36
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 7.33
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 7.33
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 7.3
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 7.22
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 7.18
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 7.09
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 7.09
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 7.09
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 7.07
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 7.06
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 7.02
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 7.02
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 7.01
T47D RNA-seq and ChrRNA-seq data 6.97
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 6.97
Hepatocyte maturation 6.91
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 6.89
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 6.84
Gene expression profile in breast cancer cells 6.84
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 6.82
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 6.76
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 6.6
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 6.57
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 6.55
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 6.46
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 6.46
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 6.46
Identification of renal resident macrophages across species 6.36
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 6.26
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 6.15
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.13
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.13
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 6.12
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 6.12
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 6.04
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.03
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 6.02
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 5.87
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 5.87
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 5.84
nELAVL HITS-CLIP in Alzheimer's Disease patients 5.81
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 5.8
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 5.79
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 5.68
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 5.68
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.54
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.51
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.5
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.45
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 5.37
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 5.35
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 5.34
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 5.33
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.33
Gene expression signatures of innate lymphoid cells from human blood 5.3
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 5.29
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 5.28
ARID1A and ARID1B loss in HCT116 and TOV21G cells 5.25
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 5.24
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 5.17
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 5.09
Cellular response to hepatitis E virus (HEV) infection 5.08
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 5.02
Loss of CREBBP results in gene expression repression in lymphoma cells 5.02
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 4.98
METTL3 and WTAP 4.98
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.89
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 4.88
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 4.75
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.75
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 4.71
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 4.68
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.65
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 4.65
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.59
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 4.52
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 4.5
Profiling of escape kinetics of viruses subjected to RNAi 4.49
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 4.48
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 4.46
Human Treg IFNg/IL-10 subpopulations 4.39
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 4.39
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 4.36
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 4.36
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 4.3
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 4.29
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 4.29
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.28
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.28
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 4.28
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 4.23
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 4.23
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 4.2
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 4.2
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 4.1
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.07
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 4.05
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.99
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 3.98
Identification of HOXB13 target genes responsive to BET inhibitors 3.97
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 3.95
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 3.94
Endothelial gene expression analysis 3.9
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 3.9
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.87
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.87
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 3.87
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.83
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.8
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.8
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.74
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 3.74
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 3.74
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.7
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 3.7
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 3.69
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 3.54
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.51
Universal alternative splicing of noncoding exons 3.5
Modeling Human Cancer-induced Cachexia (Human) 3.42
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 3.35
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 3.32
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 3.32
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 3.31
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 3.3
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 3.3
Differences in miRNA Detection Levels are Technology and Sequence Dependent 3.3
Effect of ILF3 on translation during homeostasis and the antiviral response 3.3
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 3.29
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 3.28
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 3.28
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 3.24
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 3.24
Aging-associated patterns in the expression of human endogenous retroviruses 3.21
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 3.19
Triple vectors expand AAV transfer capacity in the retina 3.18
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.16
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.11
Transcriptome profiling of A2M treated A549 Cell Line Samples 3.11
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 3.05
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.0
Anti-inflammatory effect of indoleacrylic acid (IA) 3.0
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.97
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.97
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 2.95
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.94
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 2.93
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.91
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 2.88
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 2.88
Hypoxic transcriptome of SQ20B human head and neck cancer cells 2.87
Mapping interactions for the TNIP2 hub protein 2.8
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 2.8
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 2.8
Integrin signaling regulates YAP/TAZ to control skin homeostasis 2.7
Characterization of the Merkel cell carcinoma miRNome 2.69
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.67
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.64
A single-cell transcriptome atlas of the human pancreas 2.63
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.62
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.6
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.6
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 2.59
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 2.57
Global expression profiles in cardiac progenitor cells generated by ISX-9 2.57
High-resolution comparative analysis of great ape genomes 2.55
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.54
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.53
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.5
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.5
p53 activity results in DNA replication fork processivity 2.5
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 2.5
6mer seed toxicity in tumour suppressive microRNAs 2.48
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.46
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 2.46
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.45
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.45
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.44
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 2.41
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.36
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.34
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 2.28
Metabolism as an early predictor of DPSCs aging 2.26
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 2.21
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 2.19
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.19
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.07
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.07
Global transcriptome analysis of WT versus HEB-/- hESCs 2.07
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 1.96
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.95
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.94
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.93
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 1.9
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 1.9
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 1.86
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.85
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 1.83
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 1.74
Gene expression analysis of human adenomas. 1.73
Gene expression analysis in response to hypoxic pathway inhibition 1.7
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.7
Activity-dependent transcriptional changes in human neurons 1.68
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 1.68
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.57
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.55
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.55
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.51
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 1.48
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.45
Human Tfh cell RNA bulk sequencing 1.39
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.39
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.39
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.36
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.36
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.36
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.36
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 1.36
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 1.36
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 1.35
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 1.33
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 1.27
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 1.27
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.26
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.24
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.21
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.21
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.2
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.17
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.17
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.15
Human Treg IL-12 stimulation 1.13
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.11
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 1.11
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.06
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 1.04
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.02
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.01
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.99
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.98
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.94
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.92
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.92
siRNA-mediated knockdown 0.91
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.91
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.91
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.85
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.84
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.83
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.83
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.81
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.81
Retinoic acid suppresses MYB in adenoid cystic carcinoma 0.78
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 0.78
MARS Seq data from human cortical organoids 0.77
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.76
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.75
A code of mono-phosphorylation modulates the function of RB. 0.74
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.71
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.7
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.68
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.68
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.64
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 0.61
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 0.59
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.57
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.56
EGR1-controlled transcriptome of T HESCs 0.51
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.5
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.49
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.45
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.45
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.4
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.38
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.34
Genome-wide analysis of the Integrator complex (HTS) 0.32
Genome-wide analysis of the Integrator complex 0.32
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.31
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.3
Gene induction by the USP6 oncogene in response to interferon 0.29
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.28
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 0.26
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.23
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.23
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.22
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.21
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.19
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.19
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.19
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 0.13
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.13
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 0.09
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.08
Metastasis in triple-negative breast cancer 0.08
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.08
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.05
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation